Investigating human disease using stem cell models

Tractable and accurate disease models are essential for understanding disease pathogenesis and for developing new therapeutics. As stem cells are capable of self-renewal and differentiation, they are ideally suited both for generating these models and for obtaining the large quantities of cells required for drug development and transplantation therapies. Although proof of principle for the use of adult stem cells and embryonic stem cells in disease modelling has been established, induced pluripotent stem cells (iPSCs) have demonstrated the greatest utility for modelling human diseases. Furthermore, combining gene editing with iPSCs enables the generation of models of genetically complex disorders.

[1]  Yang Xu,et al.  Modeling disease in human ESCs using an efficient BAC-based homologous recombination system. , 2010, Cell stem cell.

[2]  S. Mitalipov,et al.  Human Embryonic Stem Cells Derived by Somatic Cell Nuclear Transfer , 2013, Cell.

[3]  M. Burns,et al.  Case-Control Study , 2020, Definitions.

[4]  A. Bradley,et al.  Targeted gene correction of α1-antitrypsin deficiency in induced pluripotent stem cells , 2011, Nature.

[5]  Yoon-Young Jang,et al.  Efficient drug screening and gene correction for treating liver disease using patient‐specific stem cells , 2013, Hepatology.

[6]  S. Willadsen,et al.  Mitochondrial DNA heteroplasmy after human ooplasmic transplantation. , 2000, Fertility and sterility.

[7]  Keiichiro Suzuki,et al.  Efficient and accurate homologous recombination in hESCs and hiPSCs using helper-dependent adenoviral vectors. , 2012, Molecular therapy : the journal of the American Society of Gene Therapy.

[8]  Daniel T. Montoro,et al.  Characterization of Human Huntington's Disease Cell Model from Induced Pluripotent Stem Cells , 2010, PLoS currents.

[9]  Yoshiki Sasai,et al.  Self-formation of optic cups and storable stratified neural retina from human ESCs. , 2012, Cell stem cell.

[10]  C. Dang,et al.  Human-induced pluripotent stem cells from blood cells of healthy donors and patients with acquired blood disorders. , 2009, Blood.

[11]  Shinsuke Yuasa,et al.  Disease characterization using LQTS-specific induced pluripotent stem cells. , 2012, Cardiovascular research.

[12]  Lisle W. Blackbourn,et al.  Modeling ALS with iPSCs reveals that mutant SOD1 misregulates neurofilament balance in motor neurons. , 2014, Cell stem cell.

[13]  R. Yolken,et al.  Human Induced Pluripotent Stem Cell-Derived Models to Investigate Human Cytomegalovirus Infection in Neural Cells , 2012, PloS one.

[14]  S. Yamanaka,et al.  Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined Factors , 2006, Cell.

[15]  Christine L Mummery,et al.  Differentiation of human embryonic stem cells and induced pluripotent stem cells to cardiomyocytes: a methods overview. , 2012, Circulation research.

[16]  Simona Casini,et al.  Isogenic human pluripotent stem cell pairs reveal the role of a KCNH2 mutation in long-QT syndrome , 2013, The EMBO journal.

[17]  Woong Sun,et al.  Rapid induction and long-term self-renewal of primitive neural precursors from human embryonic stem cells by small molecule inhibitors , 2011, Proceedings of the National Academy of Sciences.

[18]  G. Church,et al.  CAS9 transcriptional activators for target specificity screening and paired nickases for cooperative genome engineering , 2013, Nature Biotechnology.

[19]  O. Yanuka,et al.  Developmental study of fragile X syndrome using human embryonic stem cells derived from preimplantation genetically diagnosed embryos. , 2007, Cell stem cell.

[20]  S. Salani,et al.  Genetic Correction of Human Induced Pluripotent Stem Cells from Patients with Spinal Muscular Atrophy , 2012, Science Translational Medicine.

[21]  Robert Passier,et al.  Prediction of drug-induced cardiotoxicity using human embryonic stem cell-derived cardiomyocytes. , 2010, Stem cell research.

[22]  T. Ichisaka,et al.  Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors , 2007, Cell.

[23]  J. Trinh,et al.  A comparative study of Parkinson's disease and leucine-rich repeat kinase 2 p.G2019S parkinsonism , 2014, Neurobiology of Aging.

[24]  Philip Roelandt,et al.  Human pluripotent stem cell-derived hepatocytes support complete replication of hepatitis C virus. , 2012, Journal of hepatology.

[25]  Chad A. Cowan,et al.  Enhanced efficiency of human pluripotent stem cell genome editing through replacing TALENs with CRISPRs. , 2013, Cell stem cell.

[26]  Ludovic Vallier,et al.  Modeling inherited metabolic disorders of the liver using human induced pluripotent stem cells. , 2010, The Journal of clinical investigation.

[27]  R. Weksberg,et al.  Isolation of MECP2-null Rett Syndrome patient hiPS cells and isogenic controls through X-chromosome inactivation , 2011, Human molecular genetics.

[28]  Laura Iop,et al.  Dantrolene rescues arrhythmogenic RYR2 defect in a patient-specific stem cell model of catecholaminergic polymorphic ventricular tachycardia , 2012, EMBO molecular medicine.

[29]  H. Tanke,et al.  Rapid flow cytometric method for measuring senescence associated β‐galactosidase activity in human fibroblasts , 2009, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[30]  R. Dolmetsch,et al.  Timothy Syndrome is associated with activity-dependent dendritic retraction in rodent and human neurons , 2012, Nature Neuroscience.

[31]  Robert V Farese,et al.  Induced pluripotent stem cell models of progranulin-deficient frontotemporal dementia uncover specific reversible neuronal defects. , 2012, Cell reports.

[32]  Kun-Yong Kim,et al.  Neuronal maturation defect in induced pluripotent stem cells from patients with Rett syndrome , 2011, Proceedings of the National Academy of Sciences.

[33]  Ludovic Vallier,et al.  Generation of Multipotent Foregut Stem Cells from Human Pluripotent Stem Cells , 2013, Stem cell reports.

[34]  L. Petrucelli,et al.  Targeting RNA Foci in iPSC-Derived Motor Neurons from ALS Patients with a C9ORF72 Repeat Expansion , 2013, Science Translational Medicine.

[35]  James A. Thomson,et al.  Induced pluripotent stem cells from a spinal muscular atrophy patient , 2009, Nature.

[36]  David A. Scott,et al.  Double Nicking by RNA-Guided CRISPR Cas9 for Enhanced Genome Editing Specificity , 2013, Cell.

[37]  C. Walsh,et al.  Somatic Mutation, Genomic Variation, and Neurological Disease , 2013, Science.

[38]  M. Weiss,et al.  Self-renewing endodermal progenitor lines generated from human pluripotent stem cells. , 2012, Cell stem cell.

[39]  S. Mitalipov,et al.  Towards germline gene therapy of inherited mitochondrial diseases , 2012, Nature.

[40]  H. Okano,et al.  Modeling familial Alzheimer's disease with induced pluripotent stem cells. , 2011, Human molecular genetics.

[41]  Lior Gepstein,et al.  Modelling the long QT syndrome with induced pluripotent stem cells , 2011, Nature.

[42]  E. Tolosa,et al.  Age at Onset in LRRK2-Associated PD is Modified by SNCA Variants , 2012, Journal of Molecular Neuroscience.

[43]  S. Haggarty,et al.  Epigenetic Characterization of the FMR1 Gene and Aberrant Neurodevelopment in Human Induced Pluripotent Stem Cell Models of Fragile X Syndrome , 2011, PloS one.

[44]  B. Miller,et al.  Modeling key pathological features of frontotemporal dementia with C9ORF72 repeat expansion in iPSC-derived human neurons , 2013, Acta Neuropathologica.

[45]  E. Furth,et al.  An iPSC line from human pancreatic ductal adenocarcinoma undergoes early to invasive stages of pancreatic cancer progression. , 2013, Cell reports.

[46]  C. Mummery,et al.  Cardiomyocytes Derived From Pluripotent Stem Cells Recapitulate Electrophysiological Characteristics of an Overlap Syndrome of Cardiac Sodium Channel Disease , 2012, Circulation.

[47]  A. Consiglio,et al.  Interplay of LRRK2 with chaperone-mediated autophagy , 2013, Nature Neuroscience.

[48]  W. Seeley,et al.  Genetic Correction of Tauopathy Phenotypes in Neurons Derived from Human Induced Pluripotent Stem Cells , 2013, Stem cell reports.

[49]  He Huang,et al.  Brief Report: Phenotypic Rescue of Induced Pluripotent Stem Cell‐Derived Motoneurons of a Spinal Muscular Atrophy Patient , 2011, Stem cells.

[50]  A. Haverich,et al.  Small intestinal submucosa segments as matrix for tissue engineering: review. , 2013, Tissue engineering. Part B, Reviews.

[51]  M. Morad,et al.  Ca2+ signaling in human induced pluripotent stem cell-derived cardiomyocytes (iPS-CM) from normal and catecholaminergic polymorphic ventricular tachycardia (CPVT)-afflicted subjects. , 2013, Cell calcium.

[52]  J. Sinclair,et al.  Mitochondrial transfer between oocytes: potential applications of mitochondrial donation and the issue of heteroplasmy. , 1998, Human reproduction.

[53]  Walaa F. Alsanie,et al.  Characterization of forebrain neurons derived from late-onset Huntington's disease human embryonic stem cell lines , 2012, Front. Cell. Neurosci..

[54]  Lief E. Fenno,et al.  SNCA Triplication Parkinson's Patient's iPSC-derived DA Neurons Accumulate α-Synuclein and Are Susceptible to Oxidative Stress , 2011, PloS one.

[55]  M. Mattson,et al.  A Targeted Neuroglial Reporter Line Generated by Homologous Recombination in Human Embryonic Stem Cells , 2009, Stem cells.

[56]  Teng Hong Tan,et al.  Modeling type 3 long QT syndrome with cardiomyocytes derived from patient-specific induced pluripotent stem cells. , 2013, International journal of cardiology.

[57]  E. Kirkness,et al.  Somatic coding mutations in human induced pluripotent stem cells , 2011, Nature.

[58]  Ian A. Trounce,et al.  Mitochondrial DNA copy number is regulated in a tissue specific manner by DNA methylation of the nuclear-encoded DNA polymerase gamma A , 2012, Nucleic acids research.

[59]  Christine Klein,et al.  Pharmacological Rescue of Mitochondrial Deficits in iPSC-Derived Neural Cells from Patients with Familial Parkinson’s Disease , 2012, Science Translational Medicine.

[60]  M. Longaker,et al.  Skeletogenic phenotype of human Marfan embryonic stem cells faithfully phenocopied by patient-specific induced-pluripotent stem cells , 2011, Proceedings of the National Academy of Sciences.

[61]  L. Rubin,et al.  A small molecule screen in stem-cell-derived motor neurons identifies a kinase inhibitor as a candidate therapeutic for ALS. , 2013, Cell stem cell.

[62]  J. Mendell,et al.  Astrocytes from Familial and Sporadic ALS Patients are Toxic to Motor Neurons , 2011, Nature Biotechnology.

[63]  박찬영.  Using iPSC-derived neurons to uncover cellular phenotypes associated with Timothy syndrome , 2012 .

[64]  Dong Ryul Lee,et al.  Quantitative proteomic analysis of induced pluripotent stem cells derived from a human Huntington's disease patient. , 2012, The Biochemical journal.

[65]  J. Yates,et al.  Progressive degeneration of human neural stem cells caused by pathogenic LRRK2 , 2012, Nature.

[66]  Nipun A. Mistry,et al.  RNA Toxicity from the ALS/FTD C9ORF72 Expansion Is Mitigated by Antisense Intervention , 2013, Neuron.

[67]  P. Mali,et al.  Site-specific gene correction of a point mutation in human iPS cells derived from an adult patient with sickle cell disease. , 2011, Blood.

[68]  H. Okano,et al.  Mitochondrial dysfunction associated with increased oxidative stress and α-synuclein accumulation in PARK2 iPSC-derived neurons and postmortem brain tissue , 2012, Molecular Brain.

[69]  S. Finkbeiner,et al.  Astrocyte pathology and the absence of non-cell autonomy in an induced pluripotent stem cell model of TDP-43 proteinopathy , 2013, Proceedings of the National Academy of Sciences.

[70]  R. Livesey.  A human stem cell model of early Alzheimer's disease pathology in Down syndrome , 2012, Alzheimer's & Dementia.

[71]  H. Tanke,et al.  Chronic inhibition of the respiratory chain in human fibroblast cultures: differential responses related to subject chronological and biological age. , 2012, The journals of gerontology. Series A, Biological sciences and medical sciences.

[72]  John R. Yates,et al.  Isogenic Human iPSC Parkinson’s Model Shows Nitrosative Stress-Induced Dysfunction in MEF2-PGC1α Transcription , 2013, Cell.

[73]  Jia Wang,et al.  Highly efficient induction and long-term maintenance of multipotent cardiovascular progenitors from human pluripotent stem cells under defined conditions , 2013, Cell Research.

[74]  Dong Wook Han,et al.  Direct reprogramming of fibroblasts into neural stem cells by defined factors. , 2012, Cell stem cell.

[75]  T. Gillis,et al.  Induced pluripotent stem cells from patients with Huntington's disease show CAG-repeat-expansion-associated phenotypes. , 2012, Cell stem cell.

[76]  Azra Fatima,et al.  In vitro Modeling of Ryanodine Receptor 2 Dysfunction Using Human Induced Pluripotent Stem Cells , 2011, Cellular Physiology and Biochemistry.

[77]  J. Buxbaum,et al.  Enhanced Striatal Dopamine Transmission and Motor Performance with LRRK2 Overexpression in Mice Is Eliminated by Familial Parkinson's Disease Mutation G2019S , 2010, The Journal of Neuroscience.

[78]  Kristopher L. Nazor,et al.  Probing sporadic and familial Alzheimer’s disease using induced pluripotent stem cells , 2012, Nature.

[79]  Donald M Bers,et al.  Drug Screening Using a Library of Human Induced Pluripotent Stem Cell–Derived Cardiomyocytes Reveals Disease-Specific Patterns of Cardiotoxicity , 2013, Circulation.

[80]  E. Tolosa,et al.  Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study , 2008, The Lancet Neurology.

[81]  D. Krainc,et al.  Mitochondrial Parkin Recruitment Is Impaired in Neurons Derived from Mutant PINK1 Induced Pluripotent Stem Cells , 2011, The Journal of Neuroscience.

[82]  J. Langston,et al.  LRRK2 mutations cause mitochondrial DNA damage in iPSC-derived neural cells from Parkinson's disease patients: Reversal by gene correction , 2014, Neurobiology of Disease.

[83]  James A. Thomson,et al.  Homologous recombination in human embryonic stem cells , 2003, Nature Biotechnology.

[84]  O. Brüstle,et al.  A rosette-type, self-renewing human ES cell-derived neural stem cell with potential for in vitro instruction and synaptic integration , 2009, Proceedings of the National Academy of Sciences.

[85]  G. Daley,et al.  Mutant induced pluripotent stem cell lines recapitulate aspects of TDP-43 proteinopathies and reveal cell-specific vulnerability , 2012, Proceedings of the National Academy of Sciences.

[86]  Thomas Gasser,et al.  Derivation and Expansion Using Only Small Molecules of Human Neural Progenitors for Neurodegenerative Disease Modeling , 2013, PloS one.

[87]  Blake Byers,et al.  LRRK2 mutant iPSC-derived DA neurons demonstrate increased susceptibility to oxidative stress. , 2011, Cell stem cell.

[88]  Katriina Aalto-Setälä,et al.  Cell Model of Catecholaminergic Polymorphic Ventricular Tachycardia Reveals Early and Delayed Afterdepolarizations , 2012, PloS one.

[89]  G. Ananiev,et al.  Isogenic Pairs of Wild Type and Mutant Induced Pluripotent Stem Cell (iPSC) Lines from Rett Syndrome Patients as In Vitro Disease Model , 2011, PloS one.

[90]  J. Nunemacher,et al.  Optimal management of giant cell arteritis and polymyalgia rheumatica , 2012, Therapeutics and clinical risk management.

[91]  H. Hioki,et al.  Drug Screening for ALS Using Patient-Specific Induced Pluripotent Stem Cells , 2012, Science Translational Medicine.

[92]  Ke Chen,et al.  Genetic correction of β-thalassemia patient-specific iPS cells and its use in improving hemoglobin production in irradiated SCID mice , 2012, Cell Research.

[93]  D. Steinemann,et al.  Sustained Knockdown of a Disease‐Causing Gene in Patient‐Specific Induced Pluripotent Stem Cells Using Lentiviral Vector‐Based Gene Therapy , 2013, Stem cells translational medicine.

[94]  D. Krainc,et al.  Human iPSC-based modeling of late-onset disease via progerin-induced aging. , 2013, Cell stem cell.

[95]  Kevin Kim,et al.  A TALEN genome-editing system for generating human stem cell-based disease models. , 2013, Cell stem cell.

[96]  J. Keith Joung,et al.  High frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells , 2013, Nature Biotechnology.

[97]  J. Mertens,et al.  APP Processing in Human Pluripotent Stem Cell-Derived Neurons Is Resistant to NSAID-Based γ-Secretase Modulation , 2013, Stem cell reports.

[98]  Jonathan A. Bernstein,et al.  Using iPS cells to investigate cardiac phenotypes in patients with Timothy Syndrome , 2011, Nature.

[99]  David M. Gilbert,et al.  Productive Hepatitis C Virus Infection of Stem Cell-Derived Hepatocytes Reveals a Critical Transition to Viral Permissiveness during Differentiation , 2012, PLoS pathogens.

[100]  Yoshiharu Matsuura,et al.  Use of human hepatocyte-like cells derived from induced pluripotent stem cells as a model for hepatocytes in hepatitis C virus infection. , 2011, Biochemical and biophysical research communications.

[101]  R. Kalejta,et al.  Human Embryonic Stem Cell Lines Model Experimental Human Cytomegalovirus Latency , 2013, mBio.

[102]  D. Surmeier,et al.  Floor plate-derived dopamine neurons from hESCs efficiently engraft in animal models of PD , 2011, Nature.

[103]  M. Lako,et al.  Derivation and Functional Analysis of Patient-Specific Induced Pluripotent Stem Cells as an In Vitro Model of Chronic Granulomatous Disease , 2012, Stem cells.

[104]  Madeline A. Lancaster,et al.  Cerebral organoids model human brain development and microcephaly , 2013, Nature.

[105]  R. Jaenisch,et al.  Efficient targeting of expressed and silent genes in human ESCs and iPSCs using zinc-finger nucleases , 2009, Nature Biotechnology.

[106]  Robert H. Brown,et al.  Intrinsic membrane hyperexcitability of amyotrophic lateral sclerosis patient-derived motor neurons. , 2014, Cell reports.

[107]  Katriina Aalto-Setälä,et al.  Model for long QT syndrome type 2 using human iPS cells demonstrates arrhythmogenic characteristics in cell culture , 2011, Disease Models & Mechanisms.

[108]  T. Adachi,et al.  Self-organizing optic-cup morphogenesis in three-dimensional culture , 2011, Nature.

[109]  M. Memo,et al.  Disease-specific phenotypes in dopamine neurons from human iPS-based models of genetic and sporadic Parkinson's disease , 2012, EMBO molecular medicine.

[110]  Karl-Ludwig Laugwitz,et al.  Patient-specific induced pluripotent stem-cell models for long-QT syndrome. , 2010, New England Journal of Medicine.

[111]  O. Yanuka,et al.  Human Embryonic Stem Cells as Models for Aneuploid Chromosomal Syndromes , 2010, Stem cells.

[112]  Morgan L. Maeder,et al.  Pathways disrupted in human ALS motor neurons identified through genetic correction of mutant SOD1. , 2014, Cell stem cell.

[113]  Sangeeta N Bhatia,et al.  Modeling hepatitis C virus infection using human induced pluripotent stem cells , 2012, Proceedings of the National Academy of Sciences.

[114]  C. Svendsen,et al.  Inhibition of Apoptosis Blocks Human Motor Neuron Cell Death in a Stem Cell Model of Spinal Muscular Atrophy , 2012, PloS one.

[115]  Takanori Takebe,et al.  Vascularized and functional human liver from an iPSC-derived organ bud transplant , 2013, Nature.

[116]  Gordon Keller,et al.  Induced pluripotent stem cells used to reveal drug actions in a long QT syndrome family with complex genetics , 2013, The Journal of general physiology.

[117]  Torsten Kluba,et al.  Genetic correction of a LRRK2 mutation in human iPSCs links parkinsonian neurodegeneration to ERK-dependent changes in gene expression. , 2013, Cell stem cell.

[118]  Austin G Smith,et al.  The first reported generation of several induced pluripotent stem cell lines from homozygous and heterozygous Huntington's disease patients demonstrates mutation related enhanced lysosomal activity , 2012, Neurobiology of Disease.

[119]  Alexander Böcker,et al.  Discovery of inhibitors of microglial neurotoxicity acting through multiple mechanisms using a stem-cell-based phenotypic assay. , 2012, Cell stem cell.

[120]  Ali Khademhosseini,et al.  Organ-on-a-chip platforms for studying drug delivery systems. , 2014, Journal of controlled release : official journal of the Controlled Release Society.

[121]  Ofer Binah,et al.  Cardiomyocytes generated from CPVTD307H patients are arrhythmogenic in response to β-adrenergic stimulation , 2012, Journal of cellular and molecular medicine.

[122]  P. Hagerman,et al.  Neural progenitor cells from an adult patient with fragile X syndrome , 2005, BMC Medical Genetics.

[123]  Katsuhiro Yoshikawa,et al.  Modeling Alzheimer's disease with iPSCs reveals stress phenotypes associated with intracellular Aβ and differential drug responsiveness. , 2013, Cell stem cell.

[124]  Zhen Yan,et al.  Parkin controls dopamine utilization in human midbrain dopaminergic neurons derived from induced pluripotent stem cells , 2012, Nature Communications.

[125]  A. Schambach,et al.  Rescue of ATP7B function in hepatocyte-like cells from Wilson's disease induced pluripotent stem cells using gene therapy or the chaperone drug curcumin. , 2011, Human molecular genetics.

[126]  Dong Ryul Lee,et al.  Neuronal Properties, In Vivo Effects, and Pathology of a Huntington's Disease Patient‐Derived Induced Pluripotent Stem Cells , 2012, Stem cells.

[127]  H. Okano,et al.  Establishment of Induced Pluripotent Stem Cells from Centenarians for Neurodegenerative Disease Research , 2012, PloS one.

[128]  K. Eggan,et al.  Human embryonic stem cell-derived motor neurons are sensitive to the toxic effect of glial cells carrying an ALS-causing mutation. , 2008, Cell stem cell.

[129]  D. Steinemann,et al.  Gene correction of human induced pluripotent stem cells repairs the cellular phenotype in pulmonary alveolar proteinosis. , 2013, American journal of respiratory and critical care medicine.

[130]  Fred H. Gage,et al.  Modelling schizophrenia using human induced pluripotent stem cells , 2011, Nature.

[131]  P. Devroey,et al.  Derivation of human embryonic stem cell lines from embryos obtained after IVF and after PGD for monogenic disorders. , 2006, Human reproduction.

[132]  S. Anderson,et al.  A Targeted NKX2.1 Human Embryonic Stem Cell Reporter Line Enables Identification of Human Basal Forebrain Derivatives , 2011, Stem cells.

[133]  J. Heaney,et al.  Tissue-specific expression of a BAC transgene targeted to the Hprt locus in mouse embryonic stem cells. , 2004, Genomics.

[134]  Y. Chien,et al.  Human Pompe disease-induced pluripotent stem cells for pathogenesis modeling, drug testing and disease marker identification. , 2011, Human molecular genetics.

[135]  Divya Rajamohan,et al.  Drug evaluation in cardiomyocytes derived from human induced pluripotent stem cells carrying a long QT syndrome type 2 mutation , 2011, European heart journal.

[136]  Tobias Wittkop,et al.  Genetic correction of Huntington's disease phenotypes in induced pluripotent stem cells. , 2012, Cell stem cell.

[137]  J. Mertens,et al.  Excitation-induced ataxin-3 aggregation in neurons from patients with Machado–Joseph disease , 2011, Nature.

[138]  B. Trapnell,et al.  Use of induced pluripotent stem cells to recapitulate pulmonary alveolar proteinosis pathogenesis. , 2013, American journal of respiratory and critical care medicine.

[139]  Vania Broccoli,et al.  Rapid Generation of Functional Dopaminergic Neurons From Human Induced Pluripotent Stem Cells Through a Single‐Step Procedure Using Cell Lineage Transcription Factors , 2013, Stem cells translational medicine.